EXACT SCIENCES CORP: net intangible assets excluding goodwill
Net intangible assets excluding goodwill for EXACT SCIENCES CORP. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All EXACT SCIENCES CORP financial histories
What this measure means
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
Exact concept: us-gaap:IntangibleAssetsNetExcludingGoodwill. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2018-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 919,925,000 | USD | 2026-02-13 | 10-K · 0001124140-26-000011 |
| At date | 2024-12-31 | 1,009,693,000 | USD | 2026-02-13 | 10-K · 0001124140-26-000011 |
| At date | 2023-12-31 | 1,890,396,000 | USD | 2025-02-19 | 10-K · 0001124140-25-000020 |
| At date | 2022-12-31 | 1,956,240,000 | USD | 2024-02-21 | 10-K · 0001124140-24-000012 |
| At date | 2021-12-31 | 2,094,411,000 | USD | 2023-02-21 | 10-K · 0001124140-23-000014 |
| At date | 2020-12-31 | 847,123,000 | USD | 2022-02-22 | 10-K · 0001124140-22-000022 |
| At date | 2019-12-31 | 1,143,550,000 | USD | 2021-02-16 | 10-K · 0001124140-21-000029 |
| At date | 2018-12-31 | 29,002,000 | USD | 2020-02-21 | 10-K · 0001124140-20-000010 |
Related financial histories
- EXACT SCIENCES CORP: total assets
- EXACT SCIENCES CORP: total liabilities
- EXACT SCIENCES CORP: stockholders equity
- EXACT SCIENCES CORP: cash and cash equivalents
- EXACT SCIENCES CORP: net income or loss
- EXACT SCIENCES CORP: operating cash flow
- EXACT SCIENCES CORP: capital expenditure payments
- EXACT SCIENCES CORP: revenue
- EXACT SCIENCES CORP: contract revenue excluding tax
- EXACT SCIENCES CORP: financing cash flow
- EXACT SCIENCES CORP: investing cash flow
- EXACT SCIENCES CORP: retained earnings or deficit
- EXACT SCIENCES CORP: basic weighted-average shares
- EXACT SCIENCES CORP: diluted weighted-average shares
- EXACT SCIENCES CORP: basic earnings per share
- EXACT SCIENCES CORP: diluted earnings per share
- EXACT SCIENCES CORP: income tax expense or benefit
- EXACT SCIENCES CORP: net property, plant and equipment
- EXACT SCIENCES CORP: share-based compensation expense
- EXACT SCIENCES CORP: operating income or loss
- EXACT SCIENCES CORP: current assets
- EXACT SCIENCES CORP: interest expense
- EXACT SCIENCES CORP: current liabilities
- EXACT SCIENCES CORP: current accounts payable
- EXACT SCIENCES CORP: goodwill carrying amount
- EXACT SCIENCES CORP: net finite-lived intangible assets
- EXACT SCIENCES CORP: net current accounts receivable
- EXACT SCIENCES CORP: operating expenses
- EXACT SCIENCES CORP: net inventory
- EXACT SCIENCES CORP: gross profit
- EXACT SCIENCES CORP: cost of revenue
- EXACT SCIENCES CORP: research and development expense
- EXACT SCIENCES CORP: common shares outstanding
- EXACT SCIENCES CORP: cash including restricted cash
- EXACT SCIENCES CORP: accumulated other comprehensive income or loss
- EXACT SCIENCES CORP: operating lease right-of-use asset
- EXACT SCIENCES CORP: operating lease liability
- EXACT SCIENCES CORP: long-term debt
- EXACT SCIENCES CORP: gross property, plant and equipment
- EXACT SCIENCES CORP: accumulated depreciation on property, plant and equipment
- EXACT SCIENCES CORP: other noncurrent assets
- EXACT SCIENCES CORP: other noncurrent liabilities
- EXACT SCIENCES CORP: accrued current liabilities
- EXACT SCIENCES CORP: prepaid expenses and other current assets
- EXACT SCIENCES CORP: current contract liabilities
- EXACT SCIENCES CORP: net deferred tax assets
- EXACT SCIENCES CORP: pre-tax income or loss from continuing operations
- EXACT SCIENCES CORP: profit or loss including noncontrolling interests
- EXACT SCIENCES CORP: comprehensive income or loss
- EXACT SCIENCES CORP: net income available to common stockholders
- EXACT SCIENCES CORP: general and administrative expense
- EXACT SCIENCES CORP: depreciation expense
- EXACT SCIENCES CORP: depreciation, depletion and amortization
- EXACT SCIENCES CORP: amortization of intangible assets
- EXACT SCIENCES CORP: nonoperating interest expense
- EXACT SCIENCES CORP: nonoperating income or expense
- EXACT SCIENCES CORP: deferred income tax expense or benefit
- EXACT SCIENCES CORP: interest paid, net
- EXACT SCIENCES CORP: proceeds from issuing common stock
- EXACT SCIENCES CORP: operating lease payments
- EXACT SCIENCES CORP: change in accounts receivable
- EXACT SCIENCES CORP: change in inventories
- EXACT SCIENCES CORP: change in accounts payable
Inspect the source
- Entity
- EXACT SCIENCES CORP / CIK 0001124140
- Captured
- 2026-09-21T17:18:30.459Z
- SEC response SHA-256
427d37573e56fe16b1fe8938f72a2bf604a44830ba1903afa76059c492ce29ac
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001124140.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))